Welcome to our dedicated page for IPERIONX SEC filings (Ticker: IPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on IPERIONX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into IPERIONX's regulatory disclosures and financial reporting.
IPERIONX Ltd director Beverly Wyse exercised options to acquire 106,093 IPX Ordinary Shares at 0.8700 in Australian dollars per share that were exercisable until December 5, 2026. After the exercise she directly holds 745,868 ordinary shares plus 84,771 RSUs, with 70,609 vesting in December 2026 and 14,162 in December 2027; no open‑market sale is reported.
IPERIONX Ltd director R Tony Tripeny bought 3,846 American Depository Shares (ADS) on July 14, 2026 at $26 per ADS in an open-market purchase. After the trade, he directly holds 8,033 ADS, 51,010 Restricted Stock Units and 38,777 IPX ordinary shares.
IPERIONX Ltd director Lorraine M. Martin purchased 4,100 American Depository Shares (ADS) of IPX at $24.51 per ADS in an open-market transaction on July 10, 2026. Following the trade, she holds 8,855 ADS, 1,177,138 ordinary shares and 90,216 RSUs, with 76,054 RSUs vesting in December 2026 and 14,162 in December 2027. Each ADS is equivalent to 10 ordinary shares.
IPERIONX Ltd President Toby Edgcumbe Symonds reported an open-market purchase of 2,040 American Depository Shares (ADS) of IPX at $24.55 per ADS, representing 20,400 Ordinary Shares. Following this trade, he holds 39,040 ADS, equivalent to 390,400 Ordinary Shares, plus 3,128,089 IPX Ordinary Shares directly. He also holds 703,199 RSUs and a substantial package of options and performance rights over additional Ordinary Shares at exercise prices between A$4 and A$22, with expirations between 2028 and 2031.
IPERIONX Ltd Chief Executive Officer Anastasios Arima reported an open-market purchase of 138,720 IPX Ordinary Shares on July 10, 2026 at an average price of A$3.5844 per share, bringing his directly held Ordinary Shares to 12,455,502. He also directly holds 738,576 Restricted Stock Units, multiple option and performance-right awards over Ordinary Shares at exercise prices between A$6 and A$22, and 128,000 American Depository Shares (ADS), each ADS representing ten Ordinary Shares.
IPERIONX Ltd Executive Chairman Todd Hannigan reported open-market purchases of IPX Ordinary Shares. He bought 225,000 shares on July 10, 2026 at an average price of $3.5786 per share and 300,000 shares on July 13, 2026 at $3.5866 per share, for total recent purchases of 525,000 shares. Following these transactions, he directly holds 26,633,334 Ordinary Shares, along with 454,464 RSUs, 500,000 ADS (each ADS convertible into 10 Ordinary Shares), and various options and performance rights over additional Ordinary Shares.
IperionX Limited is conducting an underwritten public offering of 2,275,000 American Depositary Shares at $21.98 per ADS, for aggregate gross proceeds of about $50 million before fees and expenses. Each ADS represents 10 ordinary shares, totaling 22,750,000 ordinary shares.
The offering is led by U.S. institutional investors and is expected to close on July 9, 2026, subject to customary conditions. IperionX plans to use the proceeds to commercialize and scale its titanium and metal alloy production technologies, expand its Titanium Manufacturing Campus in Virginia, advance the Camden-Titan Project in Tennessee, and for general corporate purposes. Cantor Fitzgerald is sole book-running manager, with Roth Capital Partners and B. Riley Securities as co-managers.
IperionX Limited is conducting a firm commitment public offering of 2,275,000 ADSs, each ADS representing ten ordinary shares, at a public offering price of $21.98 per ADS. The offering is being sold by the company and is expected to deliver proceeds to the issuer.
Net proceeds are estimated at approximately $46.0 million after underwriting discounts, commissions and estimated offering expenses. The ADSs are listed on Nasdaq under the symbol IPX. Ordinary shares outstanding immediately after this offering are stated as 359,072,679 ordinary shares.
IperionX Limited proposes a firm commitment public offering of American Depositary Shares (ADSs), each representing 10 ordinary shares, to raise capital to advance commercialization and scale-up of its titanium production technologies and to support the Titan-Camden critical minerals development.
Recent operational and financing context disclosed includes HAMR™ powder production of approximately 4.2 metric tons in March 2026 (about 50 metric tons per year annualized), a US$47.1 million Industrial Base Analysis and Sustainment award supporting a 1,400 metric tons per year expansion program, receipt of approximately 290 metric tons of titanium scrap from the U.S. Government, and US$48.2 million in cash as of March 31, 2026. The prospectus supplement describes use of proceeds for Virginia manufacturing scale-up, Titan-Camden activities and general corporate purposes.
IperionX Limited has completed the strategic acquisition of the Camden critical mineral, property, and infrastructure assets in Tennessee, adjacent to its Titan Critical Minerals Project. Camden brings ultra-high-grade surface stockpiles of total heavy minerals (THM), with bulk samples grading 9.9% and 23.0% THM, significantly above Titan’s 2.2% THM resource grade.
The acquisition secures mineral rights, pre-stripped Lower McNairy mineralized areas across approximately 180 acres, and an existing industrial processing hub with power, water, gas and rail. Camden’s stockpiles and pre-stripped zones may provide a higher-grade, potentially lower-capital-intensity pathway for titanium, zircon and heavy rare earth feedstocks.
IperionX plans drilling and resource-definition work at Camden to quantify the stockpiled and pre-stripped material, aiming to support an integrated Camden-Titan platform for U.S.-sourced titanium, zircon and rare-earth-bearing mineral products used in defense, aerospace, electrification and high-performance magnet technologies.